Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists

Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists

US Patent 8314092 · Granted Nov 20, 2012

Estimated economic value: $112,535,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

SSTR4 agonist salts2025
IL-17A inhibitors2025
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-2024
Disubstituted pyrazole compounds2024
SSTR4 agonist salts2023
Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-2023
Solid forms of 7-[[(1S)-1-[4-[(1S)-2-cyclopropyl-1-(4-prop-2-enoylpiperazin-1-yl2023
Glucagon-like peptide1 receptor agonists2023
TrkA Inhibitor2022
Electroacoustic driver housing element2022
Disubstituted pyrazole compounds2021
CGRP receptor antagonists2021